347 related articles for article (PubMed ID: 27817242)
1. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
Skariyachan S; Parveen A; Garka S
J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
[TBL] [Abstract][Full Text] [Related]
2. Paradigm Shift in Drug Re-purposing From Phenalenone to Phenaleno-Furanone to Combat Multi-Drug Resistant
Mujawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2018; 8():402. PubMed ID: 30488026
[TBL] [Abstract][Full Text] [Related]
3. Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays.
Skariyachan S; Manjunath M; Bachappanavar N
J Biomol Struct Dyn; 2019 Mar; 37(5):1146-1169. PubMed ID: 29529934
[TBL] [Abstract][Full Text] [Related]
4. Exploring insights for virulent gene inhibition of multidrug resistant Salmonella typhi, Vibrio cholerae, and Staphylococcus areus by potential phytoligands via in silico screening.
Skariyachan S; Jayaprakash N; Bharadwaj N; Narayanappa R
J Biomol Struct Dyn; 2014; 32(9):1379-95. PubMed ID: 23876154
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the multidrug efflux transporter styMdtM from Salmonella enterica serovar Typhi.
Shaheen A; Ismat F; Iqbal M; Haque A; Ul-Haq Z; Mirza O; De Zorzi R; Walz T; Rahman M
Proteins; 2021 Sep; 89(9):1193-1204. PubMed ID: 33983672
[TBL] [Abstract][Full Text] [Related]
6. Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant
Skariyachan S; Gopal D; Kadam SP; Muddebihalkar AG; Uttarkar A; Niranjan V
J Biomol Struct Dyn; 2021 Feb; 39(3):1121-1137. PubMed ID: 32036742
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries.
Chuang CH; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; VAN PH; Chongthaleong A; Hsueh PR; Liu JW; Song JH; Chiu CH
Epidemiol Infect; 2009 Feb; 137(2):266-9. PubMed ID: 18474127
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of current patterns and predictive trends of multidrug-resistant Salmonella Typhi in Sudan.
Elshayeb AA; Ahmed AA; El Siddig MA; El Hussien AA
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):73. PubMed ID: 29137627
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity index of antimicrobial agents as a simple solution for multidrug resistance in Salmonella Typhi.
Achla P; Grover SS; Bhatia R; Khare S
Indian J Med Res; 2005 Mar; 121(3):185-93. PubMed ID: 15802761
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility pattern and plasmid profile of multidrug resistant Salmonella typhi.
Reddy KR; Rajesh PK; Krishnan M; Sekar U
Indian J Med Microbiol; 2005 Jul; 23(3):208. PubMed ID: 16100438
[No Abstract] [Full Text] [Related]
11. In vitro activity of gentamicin and amikacin against Salmonella enterica serovar Typhi: a search for a treatment regimen for typhoid fever.
Mandal S; Mandal MD; Pal NK
East Mediterr Health J; 2009; 15(2):264-8. PubMed ID: 19554971
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomics study for identification of putative drug targets in Salmonella typhi Ty2.
Batool N; Waqar M; Batool S
Gene; 2016 Jan; 576(1 Pt 3):544-59. PubMed ID: 26555890
[TBL] [Abstract][Full Text] [Related]
13. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal.
Tamang MD; Oh JY; Seol SY; Kang HY; Lee JC; Lee YC; Cho DT; Kim J
Int J Antimicrob Agents; 2007 Oct; 30(4):330-5. PubMed ID: 17629465
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
[TBL] [Abstract][Full Text] [Related]
15. Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.
Misra R; Prasad KN; Amrin N; Kapoor P; Singh S; Ghar M
Trans R Soc Trop Med Hyg; 2015 Aug; 109(8):538-40. PubMed ID: 25979527
[TBL] [Abstract][Full Text] [Related]
16. Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.
Kumar M; Dahiya S; Sharma P; Sharma S; Singh TP; Kapil A; Kaur P
PLoS One; 2015; 10(5):e0126560. PubMed ID: 25962113
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012.
Das S; Samajpati S; Ray U; Roy I; Dutta S
Int J Med Microbiol; 2017 Jan; 307(1):28-36. PubMed ID: 27916384
[TBL] [Abstract][Full Text] [Related]
18. [Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008].
Bouzenoune F; Kellab Debbih K; Boudersa F; Kouhil S; Nezzar N
Med Mal Infect; 2011 Apr; 41(4):181-5. PubMed ID: 21093188
[TBL] [Abstract][Full Text] [Related]
19. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
Lee CJ; Su LH; Huang YC; Chiu CH
J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
[TBL] [Abstract][Full Text] [Related]
20. Antiquorum sensing and antibiofilm potential of biosynthesized silver nanoparticles of Myristica fragrans seed extract against MDR Salmonella enterica serovar Typhi isolates from asymptomatic typhoid carriers and typhoid patients.
Balakrishnan S; Ibrahim KS; Duraisamy S; Sivaji I; Kandasamy S; Kumarasamy A; Kumar NS
Environ Sci Pollut Res Int; 2020 Jan; 27(3):2844-2856. PubMed ID: 31836973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
